Kolexia
Belletier Christine Gastro-entérologie
Belletier Christine
Gastro-entérologie
Centre Paul Strauss
Strasbourg, France
31 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Fatigue Tumeurs du côlon Cachexie Carcinome pulmonaire non à petites cellules Adénocarcinome Tumeurs du pancréas Carcinome épidermoïde Tumeurs du sein triple-négatives Carcinomes

Collaborateurs

Voir plus
Chiappa Pascale
Chiappa Pascale
Centre Hospitalier de Selestat, Sélestat, France
Carinato Helene
Carinato Helene
Centre Paul Strauss, Strasbourg, France
Schott Roland
Schott Roland
Centre Paul Strauss, Strasbourg, France
Gantzer Justine
Gantzer Justine
Centre Paul Strauss, Strasbourg, France

Industries

Voir plus
Servier
3 collaboration(s)
Dernière en 2023
Amgen
2 collaboration(s)
Dernière en 2023
VIATRIS SANTE
2 collaboration(s)
Dernière en 2023
Mylan Medical
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
MegaMOST - A Multicenter, Open-label, Biology Driven, Phase II Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations /Characteristics in Advanced / Metastatic Tumors.
Essai Clinique (Centre Léon-Bérard)   16 novembre 2023
1517P Patient-related outcomes (PROs) after early palliative care (PC) (EPC) compared with standard oncologic care (SOC) for patients (pts) with metastatic upper gastrointestinal cancers (mUGIC): Results of the randomised EPIC trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Affective experiences during COVID-19 pandemic lockdown and posttraumatic growth: A 1-year longitudinal study in France.
Journal of affective disorders   13 mai 2022
LBA57 Unicancer PRODIGE 24/CCTG PA6 trial: Updated results of a multicenter international randomized phase III trial of adjuvant mFOLFIRINOX (mFFX) versus gemcitabine (gem) in patients (pts) with resected pancreatic ductal adenocarcinomas (PDAC)
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Evolution of Physical Status From Diagnosis to the End of First-Line Treatment in Breast, Lung, and Colorectal Cancer Patients: The PROTECT-01 Cohort Study Protocol.
Frontiers in oncology   07 août 2020
PROTECT-01: Evolution of the Physical Condition in Treated Cancer Patients
Essai Clinique (Centre Paul Strauss)   10 février 2020
Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
Oncology   07 mars 2015
Is docetaxel (D) less efficient than anthracycline-based chemotherapy (A) in triple-negative breast cancer (TNBC) treated in neoadjuvant setting?
2012 ASCO Annual Meeting I   20 mai 2012
Intérêt de l’endoscopie de réévaluation pour les carcinomes épidermoïdes de l’œsophage (420)
112e Congrès Français de Chirurgie 6-8 octobre 2010, Paris   01 septembre 2010